CMR Surgical has raised $600 million in Series D funding led by SoftBank Vising Fund 2ii and Ally Bridge Group. The announcement states that the funds will help the company to achieve its mission of making keyhole surgery more accessible and commercialize and develop the ecosystem of its new surgical robotic system called Versius.
Along with SoftBank Vision Fund 2 and Ally Bridge Group, the funding was supported by new international investors such as RPMI Railpen, Tencent, and Chimera, widening the global scope of the shareholder base. Their existing investors, inclusive of LGT, Lightrock, Innovation Capital, PFM Health Sciences, Watrium, Cambridge, and GE Healthcare, also participated in the Series D Funding.
Our $600 million Series D financing round was led by SoftBank Vision Fund 2, co-led by Ally Bridge Group, and was supported by some of our valued existing investors, as well as new investors from around the world. Read more: https://t.co/N4S0CXuH2e #TransformingSurgery pic.twitter.com/pd2aDlJyWd
— CMR Surgical (@CMRSurgical) July 1, 2021
CMR collaborates with surgeons, surgical teams, and hospitals to develop the best tool for making robotic keyhole surgery approachable and inexpensive. The versatility, compactness, and portability have made Versius, the surgical robot system, popular among hospitals and surgeons globally. As part of CMR’s global expansion, Versius has been successfully introduced worldwide in countries like Australia, India, Europe, and the Middle East. The global demand for the CMR’s surgical robot keeps rising with further momentum predicted.
Mark Slack is the Chief Medical Officer for CMR Surgical. He stated that it is incredible to be collaborating with surgeons to complete over 1,000 surgeries worldwide – a crucial milestone as CMR provides Minimal Access Surgery (MAS) to patients all around the world.
The Series D provides funding to fully implement CMR’s goal of speeding up its worldwide expansion and adds on the foundation developed by the company to grow a long-term autonomous business globally. The raised funds also help the continuous development of the system’s digital infrastructure, including new technology breakthroughs like Versius Connect, an application for surgeons for the use of Versius surgical robotic system.
Versius Surgical Robot
Versius raises the bar for robotic surgery. Versius may be used in almost any operating room arrangement and blends effortlessly into clinical workflow, enhancing the chance of robotic minimal access surgery (MAS). Versius’ versatile and flexible design enables the surgeon to use the number of arms required for a given operation.
Versius, which mimics the human arm, provides surgeons with the option of optimizing port placement with the agility and precision of compressed fully-wristed tools. The 3D HD vision, ease of use, and choice of a comfortable working position allow the open surgeon console the potential to decrease stress and tiredness, including transparent communication with the surgical team.
Versius collects valuable data through its larger digital environment to enhance a surgeon’s learning process. Versius unlocks a variety of insights to improve surgical treatment through the Versius Trainer, Versius Connect app, and CMR clinical registry.
Series D financing in Versius Surgical Robot will help medical surgeons globally, offering accessible and affordable treatment to the people. CMR Surgical is constantly developing and transforming surgery around the globe. Their approach and technology enable surgeons to deliver the best to patients.